Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

SFOSF

$2.20

Updated: 23/09/2026, 16:36:38

Market Cap
$5.82B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
CN
Stock valuation chart
One-year closing share-price history for SFOSF
Company Profile

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise. The company is actively engaged in the research, development, manufacturing, and sale of pharmaceutical products, serving markets across Mainland China and internationally. Its diverse operations are structured into five main segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Services, Pharmaceutical Distribution and Retail, and Other Business activities. Within its pharmaceutical portfolio, Fosun Pharma focuses on critical therapeutic areas such as oncology, immune system modulation, metabolic disorders, gastrointestinal conditions, and central nervous system ailments. Beyond its drug offerings, the company also provides a range of medical equipment and diagnostic solutions. Furthermore, SFOSF is involved in delivering healthcare services and managing hospitals, alongside its wholesale and retail distribution of medicines.

USD
OTC
CEO: Yi Liu
Employees: 40,603
https://www.fosunpharma.com
Asset Summaries
Latest generated summaries for SFOSF

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SFOSF.
Share price
$2.20
Market cap
$5.82B
Exchange
OTC
Currency
USD
CEO
Yi Liu
Employees
40,603
IPO date
21/04/2014
Beta
0.437
Last dividend
$0.00
Day range
$2.20 – $2.20
52-week range
$1.93 – $3.50
1-day performance
0.00%
1-year performance
13.87%
Current drawdown (1Y)
-37.14%
CIK
N/A
CUSIP
N/A
ISIN
CNE100001M79
Created
07/12/2025, 14:11:12
Last update
23/09/2026, 16:36:38

Track Shanghai Fosun Pharmaceutical (Group) Co., Ltd. with an AI analyst

See which prediction-market events move SFOSF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.

Latest Database News
News linked to SFOSF from your Railway `news_articles` table.

No news found for this symbol.